Charles River Laboratories International, Inc.

CRL

HealthcareNYQ$8.2B

CRL SEC filings last scanned 13 May 2026, 23:36 UTC

CEO Timeline

Birgit GirshickCurrent

May 2026 — Present(0mo)

Birgit Girshick was appointed Chief Executive Officer of Charles River Laboratories International, Inc., effective May 5, 2026, succeeding James C. Foster.

1 source filing — click to expand

James C. Foster

Since at least Mar 2005 — May 2026(21y 2mo)

planned transition

1 source filing — click to expand